Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
GTCR closes $3.6bn strategic growth fund II, surpassing target
GTCR closes $3.6bn strategic growth fund II, surpassing target GTCR closed its latest fund, Strategic Growth Fund II (SGF II), at $3.6bn, significantly exceeding its $2.75bn target. The oversubscribed fund follows Strategic Growth Fund I, which closed in 2022 with...
Schroders Capital closes £500m UK Innovation LTAF, invests in AI leaders Synthesia and Luminance
Schroders Capital closes £500m UK Innovation LTAF, invests in AI leaders Synthesia and Luminance Schroders Capital, the $97.3bn private markets specialist, has completed the first £500m close of its UK Innovation Long-Term Asset Fund (LTAF). The fund, designed to back...
Lenders push back as private equity firms test investor protections
Lenders push back as private equity firms test investor protections Lenders are pushing back against private equity firms seeking to weaken key investor protections in leveraged debt markets. Despite a strong credit market favoring borrowers, creditors are refusing to...